ALMA LOVERES: Open Payments
NPI 1083061410 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 30 payments from 13 companies in 2025. Trend: 2023 $841 · 2024 $1,015 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $116 |
| PFIZER INC. | 4 | $66 |
| ABBVIE INC. | 3 | $51 |
| Amgen Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Viatris Specialty LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: SHINGRIX, VRAYLAR, Dexcom G6 Transmitter, Ozempic, AIRSUPRA, MOUNJARO, OTEZLA, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
